News|Articles|July 30, 2024
Hydrophobic Interaction Chromatography: A Platform for Characterizing Antibody-Drug Conjugates
Author(s)Tosoh Bioscience
Characterizing the ratio of tumor-killing payload to cancer-binding antibody (DAR) is a critical quality attribute that helps determine the potential potency of a given antibody-drug conjugate (ADC) candidate. The TSKgel® HIC-ADC Butyl column, developed by Tosoh Bioscience, enables improved HIC-based separations for quantifying the DAR of ADCs.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
High-throughput Headspace Analysis of Volatile Nitrosamines and their Secondary Amine Precursors
2
Best of the Week: The Scientific Method in the Age of AI, Rewiring the Fundamentals
3
Unlocking Discovery Data: Why a Digital Ecosystem Matters for HT-MS
4
Detecting Estrogen Signatures in MCN Tumors via Targeted LC-MS/MS
5
